INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 431m ago
HOUSE PTR31m ago
SEC 13F30m ago
ROBINHOOD CHAIN30m ago
Corporate insider
SF

Scharen-Guivel Hilda Frederique

DirectorCIK 0001950129

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells0 / 2
Max Insider Score32
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
28
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Open-market sale
SELL$117K
1,234 sh
Jun 4, 2026Jun 4, 2026
traded Jun 4, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    IRADIMED CORPDirector · Dec 9, 2025
32
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Open-market sale
SELL
$168K
1,766 sh
Jun 4, 2026
Jun 4, 2026
traded Jun 4, 2026
+0d
SEC FORM 4

Evidence

21
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Grant or award
A—
1,026 sh
Dec 11, 2025Dec 15, 2025
traded Dec 11, 2025
+4dSEC FORM 4

Evidence

21
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
905 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

13
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
905 sh
Dec 11, 2025Dec 12, 2025
traded Dec 11, 2025
+1dSEC FORM 4

Evidence

9
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
1,197 sh
Dec 7, 2025Dec 9, 2025
traded Dec 7, 2025
+2dSEC FORM 4

Evidence

13
SF
Scharen-Guivel Hilda FrederiqueDirector
IRMDIRADIMED CORP
Option exercise
M—
1,197 sh
Dec 7, 2025Dec 9, 2025
traded Dec 7, 2025
+2dSEC FORM 4

Evidence